Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 524

1.

Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.

DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.

Ultrasound Obstet Gynecol. 2007 Oct;30(5):697-705.

2.

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.

Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'Brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GW; PREGNANT Trial..

Ultrasound Obstet Gynecol. 2011 Jul;38(1):18-31. doi: 10.1002/uog.9017. Epub 2011 Jun 15.

3.

Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.

Klein K, Rode L, Nicolaides KH, Krampl-Bettelheim E, Tabor A; PREDICT Group..

Ultrasound Obstet Gynecol. 2011 Sep;38(3):281-7. doi: 10.1002/uog.9092.

5.

Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone.

Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim E, Tabor A; PREDICT Group..

Ultrasound Obstet Gynecol. 2011 Sep;38(3):272-80. doi: 10.1002/uog.9093.

6.

Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.

O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.

Ultrasound Obstet Gynecol. 2007 Oct;30(5):687-96.

7.

Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone.

Maher MA, Abdelaziz A, Ellaithy M, Bazeed MF.

Acta Obstet Gynecol Scand. 2013 Feb;92(2):215-22. doi: 10.1111/aogs.12017. Epub 2012 Dec 5.

PMID:
23016508
8.

Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix.

Alfirevic Z, Owen J, Carreras Moratonas E, Sharp AN, Szychowski JM, Goya M.

Ultrasound Obstet Gynecol. 2013 Feb;41(2):146-51. doi: 10.1002/uog.12300. Epub 2013 Jan 17.

9.

Treatment options and recommendations to reduce preterm births in women with short cervix.

Slager J, Lynne S.

J Midwifery Womens Health. 2012 Jul;57 Suppl 1:S12-8. doi: 10.1111/j.1542-2011.2012.00210.x.

PMID:
22776244
10.

Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.

Serra V, Perales A, Meseguer J, Parrilla JJ, Lara C, Bellver J, Grifol R, Alcover I, Sala M, Martínez-Escoriza JC, Pellicer A.

BJOG. 2013 Jan;120(1):50-7. doi: 10.1111/j.1471-0528.2012.03448.x. Epub 2012 Aug 13.

11.

Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment.

McGregor JA, French JI, Richter R, Vuchetich M, Bachus V, Seo K, Hillier S, Judson FN, McFee J, Schoonmaker J, et al.

Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1580-91.

PMID:
2240110
13.

Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial.

Dodd JM, Crowther CA, McPhee AJ, Flenady V, Robinson JS.

BMC Pregnancy Childbirth. 2009 Feb 24;9:6. doi: 10.1186/1471-2393-9-6.

14.

Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.

Conde-Agudelo A, Romero R.

Am J Obstet Gynecol. 2016 Feb;214(2):235-42. doi: 10.1016/j.ajog.2015.09.102. Epub 2015 Oct 9.

PMID:
26450404
15.

Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study.

Brizot ML, Hernandez W, Liao AW, Bittar RE, Francisco RP, Krebs VL, Zugaib M.

Am J Obstet Gynecol. 2015 Jul;213(1):82.e1-9. doi: 10.1016/j.ajog.2015.02.021. Epub 2015 Feb 27.

PMID:
25731690
16.

Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial.

O'Brien JM, Defranco EA, Adair CD, Lewis DF, Hall DR, How H, Bsharat M, Creasy GW; Progesterone Vaginal Gel Study Group..

Ultrasound Obstet Gynecol. 2009 Dec;34(6):653-9. doi: 10.1002/uog.7338.

17.

A randomized trial of micronized progesterone for the prevention of recurrent preterm birth.

Glover MM, McKenna DS, Downing CM, Smith DB, Croom CS, Sonek JD.

Am J Perinatol. 2011 May;28(5):377-81. doi: 10.1055/s-0031-1274509. Epub 2011 Mar 4.

PMID:
21380990
18.

Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety.

El-refaie W, Abdelhafez MS, Badawy A.

Arch Gynecol Obstet. 2016 Jan;293(1):61-7. doi: 10.1007/s00404-015-3767-1. Epub 2015 Jun 5.

PMID:
26044148
19.

The impact of digital cervical examination on expectantly managed preterm rupture of membranes.

Alexander JM, Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Meis PJ, Moawad AH, Iams JD, Vandorsten JP, Paul RH, Dombrowski MP, Roberts JM, McNellis D.

Am J Obstet Gynecol. 2000 Oct;183(4):1003-7.

PMID:
11035354
20.

Perinatal outcomes in women with preterm rupture of membranes between 24 and 32 weeks of gestation and a history of vaginal bleeding.

Hnat MD, Mercer BM, Thurnau G, Goldenberg R, Thom EA, Meis PJ, Moawad AH, Iams JD, Van Dorsten JP; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units..

Am J Obstet Gynecol. 2005 Jul;193(1):164-8.

PMID:
16021074

Supplemental Content

Support Center